Lipodystrophy: Results of a data evaluation of patients receiving nelfinavir-containing combination therapy [1]

Journal of Acquired Immune Deficiency Syndromes

Volumn 23, Issue 4, 2000, Pages 355-356

  Lewis, Ronald H ^a   Popescu, Matei ^b  

^a AGOURON PHARMACEUTICALS INC   (United States)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NELFINAVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LETTER; LIPODYSTROPHY; PRIORITY JOURNAL;

EID: 0034176216     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200004010-00012     Document Type: Letter

References (12)